These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
11/7/2016
11:27 AM ET
Press Release

Repligen to Participate in Stephens Inc. Fall Investment Conference 2016

11/7/2016

WALTHAM, Mass., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator and provider of high-value products to improve the process of manufacturing biologic drugs,...

 Continue Reading
11/3/2016
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2016 Financial Results

11/3/2016

WALTHAM, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the...

 Continue Reading
10/20/2016
7:30 AM ET
Press Release

Repligen to Report Third Quarter 2016 Financial Results

10/20/2016

WALTHAM, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report third quarter 2016 financial results on Thursday, November 3, 2016....

 Continue Reading
10/18/2016
7:30 AM ET
Press Release

Repligen Hires Ralf Kuriyel as Senior Vice President of Research & Development

10/18/2016

WALTHAM, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the appointment of Ralf...

 Continue Reading
10/5/2016
8:00 AM ET
Press Release

Repligen Launches Single-Use XCell™ ATF System for Bioprocess Intensification

10/5/2016

Complements Stainless Steel ATF Technology with Innovative Single-Use FormatImproves Ease of Use for Biopharmaceutical Manufacturing Customers Offers Equivalent High Performance to Stainless Steel XCe...

 Continue Reading
Displaying 1 to 5 (of 186 releases)